Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio as Predictors of Disease Severity and Mortality in Critically Ill Children: A Retrospective Cohort Study

Abstract

The aim of this study was to determine the ability of neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) to predict the severity of illness as assessed by two scoring systems, namely, Pediatric Logistic Organ Dysfunction-2 (PELOD-2) and Pediatric Risk of Mortality-III (PRISM-III) and outcome. This was a retrospective cohort study wherein all critically ill children aged 1 month to 18 years admitted in the pediatric intensive care unit from January 2021 to October 2022 were included. Children with chronic systemic diseases and hematological illness were excluded from the study. Demographic details, diagnosis, PRISM-III-24 and PELOD-2 scores at admission, and outcome were retrieved from the hospital case records. NLR and PLR values were compared among high and normal PRISM-III and PELOD-2 groups as well as among survivors and nonsurvivors. A total of 325 patients with critical illness were included with a mean (standard deviation) age of 7(5) years and a male: female ratio of 3:2. The values of NLR were significantly higher among the patients with high PRISM-III (2.2 vs. 1.3, p-value = 0.006) and PELOD-2 (2 vs. 1.4, p-value = 0.015) groups compared with normal. The NLR and PLR were significantly higher among the nonsurvivors compared with the survivors (2.3 vs. 1.4, p-value = 0.013, and 59.4 vs. 27.3, p-value = 0.016 for NLR and PLR, respectively). The area under the receiver operating characteristics curve for NLR and PLR was 0.617 and 0.609, respectively. A high PLR, PRISM-III, and PELOD-2 were the factors found to be independently associated with mortality on multiple logistic regression analysis. Patients with high NLR are associated with more severe illness at admission. NLR and PLR are useful parameters to predict mortality.

Keywords

neutrophil lymphocyte ratio - platelet lymphocyte ratio - PRISM-III - PELOD-2 - critical illness - pediatric intensive care

Publication History

Received: 04 December 2022

Accepted: 04 April 2023

Article published online:
11 May 2023

• References

• 1 Aktas G, Sit M, Tekce H. et al. Mean platelet volume in nasal polyps. West Indian Med J 2013; 62 (06) 515-518
• 2 Aktas G, Sit M, Dikbas O. et al. Could red cell distribution width be a marker in Hashimoto's thyroiditis?. Exp Clin Endocrinol Diabetes 2014; 122 (10) 572-574
• 3 Aydın İ, Ağıllı M, Aydın FN. et al. The reference ranges of neutrophil-lymphocyte ratio in different age groups. Gülhane Tip Derg 2015; 57 (04) 414
• 4 Zahorec R. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102 (01) 5-14
• 5 Karagoz I, Yoldas H. Platelet to lymphocyte and neutrophil to lymphocyte ratios as strong predictors of mortality in intensive care population. Rev Assoc Med Bras 2019; 65 (05) 633-636
• 6 Pasaribu FM, Setyaningtyas A, Andarsini MR. Neutrophil to lymphocyte ratio, monocyte to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume as a predictor of sepsis mortality in children at Dr. Soetomo General Hospital. Crit Care Shock 2021; 24 (02) 65-71
• 7 Wu X, Luo Q, Su Z. et al. Neutrophil-to-lymphocyte ratio as a predictor of mortality in intensive care unit patients: a retrospective analysis of the Medical Information Mart for Intensive Care III Database. BMJ Open 2021; 11 (11) e053548
• 8 Mısırlıoğlu M, Bekdaş M, Kabakuş N. Platelet-lymphocyte ratio in predicting mortality of patients in pediatric intensive care unit. J Clin Anal Med 2018; 9 (06) 488-492
• 9 Zhong X, Ma A, Zhang Z, Liu Y, Liang G. Neutrophil-to-lymphocyte ratio as a predictive marker for severe pediatric sepsis. Transl Pediatr 2021; 10 (03) 657-665
• 10 Mathews S, Rajan A, Soans ST. Prognostic value of rise in neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting the mortality in pediatric intensive care. Int J Contemp Pediatrics 2019; 6 (03) 1052-1058
• 11 Leteurtre S, Duhamel A, Salleron J, Grandbastien B, Lacroix J, Leclerc F. Groupe Francophone de Réanimation et d'Urgences Pédiatriques (GFRUP). PELOD-2: an update of the PEdiatric logistic organ dysfunction score. Crit Care Med 2013; 41 (07) 1761-1773
• 12 Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated pediatric risk of mortality score. Crit Care Med 1996; 24 (05) 743-752
• 13 Shenoy S, Patil S, Karunakar P, Mangalgi S, Samaga V. Comparison between paediatric risk of mortality III and paediatric logistic organ dysfunction-2 as mortality predictor in paediatric intensive care. Sri Lanka J Child Health 2023; 52 (01) 45-51
• 14 Qi X, Dong Y, Lin X, Xin W. Value of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and red blood cell distribution width in evaluating the prognosis of children with severe pneumonia. Evid Based Complement Alternat Med 2021; 2021: 1818469
• 15 Onsrud M, Thorsby E. Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol 1981; 13 (06) 573-579
• 16 Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun 1996; 10 (02) 77-91
• 17 Honda T, Uehara T, Matsumoto G, Arai S, Sugano M. Neutrophil left shift and white blood cell count as markers of bacterial infection. Clin Chim Acta 2016; 457: 46-53
• 18 Azab B, Shah N, Akerman M, McGinn Jr JT. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012; 34 (03) 326-334
• 19 Nording HM, Seizer P, Langer HF. Platelets in inflammation and atherogenesis. Front Immunol 2015; 6: 98
• 20 Kim CH, Kim SJ, Lee MJ. et al. An increase in mean platelet volume from baseline is associated with mortality in patients with severe sepsis or septic shock. PLoS One 2015; 10 (03) e0119437